Glaucoma
Conditions
Interventions
Triamcinolone acetonide 0.5:intracameral triamcinolone acetonide 0.5mg in combined phacoemulsification and trabeculectomy
Triamcinolone acetonide 1.0:intracameral triamcinolone acetonide 1.0mg in combined phacoemulsification and trabeculectomy
Triamcinolone acetonide 2.0:intracameral triamcinolone acetonide 2.0mg in combined phacoemulsification and trabeculectomy
Sponsors
Beijing Shijitan Hospital
Eligibility
Sex/Gender
All
Age
40 Years to 76 Years
Inclusion criteria
Inclusion criteria: 1. Over 40 years of age; 2. Patients with visually significant cataract with the best corrected visual acuity less than 0.5; 3. Patients with primary glaucoma with an intraocular pressure of greater than or equal to 22 mmHg despite medical therapy.
Exclusion criteria
Exclusion criteria: 1. Patients with other ocular pathologies such as cornea opacities, uveities, diabetes retinopathy, central retinal vein occlusion, et al.; 2. Secondary glaucoma because of trauma, uveities, neovascularization, et al.; 3. Past medical history of intraocular surgery; 4. Patients taking systemic immunosuppressants or adrenal corticosteroid.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Visual Acuity;Intraocular Pressure;Anterior Chamber Inflammation by cells and flar; | — |
Countries
China
Contacts
Public ContactWang Bingsong
Outcome results
None listed